North America Is Expected To Hold The Dominant Position In The Global Angioedema Treatment Market
Angioedema is a medical condition that causes swelling of the lower layer of skin and tissue just beneath the skin, as well as the mucous membrane. Angioedema is classified into four types: allergic angioedema, drug-induced angioedema, idiopathic angioedema, and hereditary angioedema (HAE). Angioedema is caused by a variety of factors, the majority of which are unknown. Angioedema is caused primarily by allergic reactions, adverse effects of medications, genetic defects, and infections. Haegarda, a C1 Esterase Inhibitor (Human) for subcutaneous administration, was approved by the US Food and Drug Administration in 2017 for the prevention of hereditary angioedema (HAE) in adult and adolescent patients. Europe's Angioedema Treatment Market is expected to grow significantly due to the increasing presence of angioedema drug manufacturers, and it is also expected to grow significantly over the forecast period due to the increasing number of new manufacturing plants in the regi...